Patents by Inventor Vladimir P. Nikolski
Vladimir P. Nikolski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220313105Abstract: A medical device is configured to obtain impedance measurements from each one of multiple impedance measurement electrode vectors and determine an estimate of impedance of body tissue or a body cavity, e.g., a thoracic impedance estimate, by computing an impedance of a circuit model of impedance using the multiple impedance measurements. The medical device may be configured to determine that the impedance estimate meets fluid condition detection criteria and detect a fluid status condition in response to the impedance estimate meeting the fluid condition detection criteria.Type: ApplicationFiled: March 3, 2022Publication date: October 6, 2022Inventors: Vladimir P. NIKOLSKI, Vinod SHARMA
-
Patent number: 11406838Abstract: An implantable medical device is configured to control a therapy module to couple a capacitor array comprising a plurality of capacitors to a plurality of extra-cardiovascular electrodes and control the therapy module to deliver a composite pacing pulse to a patient's heart via the plurality of extra-cardiovascular electrodes by sequentially discharging at least a portion of the plurality capacitors to produce a series of at least two individual pulses that define the composite pacing pulse.Type: GrantFiled: October 21, 2019Date of Patent: August 9, 2022Assignee: Medtronic, Inc.Inventors: David A. Anderson, Mark T. Marshall, Vladimir P. Nikolski, Robert T. Sawchuk, Amy E. Thompson-Nauman, John D. Wahlstrand, Gregory A. Younker
-
Publication number: 20220015800Abstract: In some examples, a system includes a medical device comprising an elongate body configured to advance through layers of tissue of a patient, a lumen extending through the elongate body, a fluid line configured to supply fluid to the lumen, and a pressure sensor positioned within the lumen or the fluid line. The system may further include processing circuitry configured to receive, from the pressure sensor, a signal corresponding to the pressure of the fluid at each of a plurality of time points, determine, for each time point: a corresponding amplitude value of the signal, a difference between two amplitude values of the signal, an amplitude oscillation status of the signal, a position of the elongate body based on the difference and the amplitude oscillation status; and provide an indication of the position of the elongate body relative to the layers of tissue.Type: ApplicationFiled: October 1, 2021Publication date: January 20, 2022Inventors: Vladimir P. Nikolski, Linnea R. Lentz, Amy E. Thompson-Nauman, Teresa A. Whitman, Mark T. Marshall
-
Patent number: 11134984Abstract: In some examples, a system includes a medical device comprising an elongate body configured to advance through layers of tissue of a patient, a lumen extending through the elongate body, a fluid line configured to supply fluid to the lumen, and a pressure sensor positioned within the lumen or the fluid line. The system may further include processing circuitry configured to receive, from the pressure sensor, a signal corresponding to the pressure of the fluid at each of a plurality of time points, determine, for each time point: a corresponding amplitude value of the signal, a difference between two amplitude values of the signal, an amplitude oscillation status of the signal, a position of the elongate body based on the difference and the amplitude oscillation status; and provide an indication of the position of the elongate body relative to the layers of tissue.Type: GrantFiled: July 31, 2018Date of Patent: October 5, 2021Assignee: Medtronic, Inc.Inventors: Vladimir P. Nikolski, Linnea R. Lentz, Amy E. Thompson-Nauman, Teresa A. Whitman, Mark T. Marshall
-
Publication number: 20210299443Abstract: A medical device is configured to deliver therapeutic electrical stimulation pulses by generating frequency modulated electrical stimulation pulse signals. The medical device includes a pulse signal source and a modulator. The pulse signal source generates an electrical stimulation pulse signal having a pulse width. The modulator may include a high frequency modulator configured to modulate a frequency of the pulse signal from a starting frequency down to a minimum frequency during the pulse width. The modulator may include a low frequency bias generator to modulate the offset of the pulse signal between a minimum offset and a maximum offset in other examples.Type: ApplicationFiled: February 15, 2021Publication date: September 30, 2021Inventors: Vladimir P. Nikolski, Melissa G.T. Christie, Mark T. Marshall, Amy E. Thompson-Nauma
-
Publication number: 20210267527Abstract: In situations in which an implantable medical device (e.g., a subcutaneous ICD) is co-implanted with a leadless pacing device (LPD), it may be important that the subcutaneous ICD knows when the LPD is delivering pacing, such as anti-tachycardia pacing (ATP). Techniques are described herein for detecting, with the ICD and based on the sensed electrical signal, pacing pulses and adjusting operation to account for the detected pulses, e.g., blanking the sensed electrical signal or modifying a tachyarrhythmia detection algorithm. In one example, the ICD includes a first pace pulse detector configured to obtain a sensed electrical signal and analyze the sensed electrical signal to detect a first type of pulses having a first set of characteristics and a second pace pulse detector configured to obtain the sensed electrical signal and analyze the sensed electrical signal to detect a second type of pulses having a second set of characteristics.Type: ApplicationFiled: May 14, 2021Publication date: September 2, 2021Inventors: James D. REINKE, Xusheng ZHANG, Vinod SHARMA, Vladimir P. NIKOLSKI, Michael B. TERRY, Scott A. HARELAND, Daniel L. HANSEN, Donna M. SALMI
-
Publication number: 20210268297Abstract: This disclosure describes implantable medical leads and medical device systems utilizing the leads. In some examples, an implantable medical lead comprises a first defibrillation electrode and a second defibrillation electrode, the first and second defibrillation electrodes configured to deliver anti-tachyarrhythmia shocks, and a pace electrode disposed between the first defibrillation electrode and the second defibrillation electrode, the pace electrode configured to deliver a pacing pulse that generates an electric field proximate to the pace electrode. The implantable medical lead further comprises a shield disposed between the first defibrillation electrode and the second defibrillation electrode and over a portion of an outer surface of the pace electrode, wherein the shield is configured to impede the electric field in a direction from the pace electrode away from a heart.Type: ApplicationFiled: February 25, 2021Publication date: September 2, 2021Inventors: Vladimir P. Nikolski, Mark T. Marshall, Jeffrey D. Wilkinson, Amy E. Thompson-Nauman
-
Patent number: 11020038Abstract: In situations in which an implantable medical device (e.g., a subcutaneous ICD) is co-implanted with a leadless pacing device (LPD), it may be important that the subcutaneous ICD knows when the LPD is delivering pacing, such as anti-tachycardia pacing (ATP). Techniques are described herein for detecting, with the ICD and based on the sensed electrical signal, pacing pulses and adjusting operation to account for the detected pulses, e.g., blanking the sensed electrical signal or modifying a tachyarrhythmia detection algorithm. In one example, the ICD includes a first pace pulse detector configured to obtain a sensed electrical signal and analyze the sensed electrical signal to detect a first type of pulses having a first set of characteristics and a second pace pulse detector configured to obtain the sensed electrical signal and analyze the sensed electrical signal to detect a second type of pulses having a second set of characteristics.Type: GrantFiled: February 19, 2019Date of Patent: June 1, 2021Assignee: Medtronic, Inc.Inventors: James D. Reinke, Xusheng Zhang, Vinod Sharma, Vladimir P. Nikolski, Michael B. Terry, Scott A. Hareland, Daniel L. Hansen, Donna M. Salmi
-
Publication number: 20210146141Abstract: In some examples, a medical device system includes an electrode. The medical device system may include impedance measurement circuitry coupled to the electrode, the impedance measurement circuitry may be configured to generate an impedance signal indicating impedance proximate to the electrode. The medical device system may include processing circuitry that may be configured to identify a first component of the impedance signal. The first component of the impedance signal may be correlated to a cardiac event. The processing circuitry may be configured to determine that the cardiac event occurred based on the identification of the first component of the impedance signal.Type: ApplicationFiled: January 25, 2021Publication date: May 20, 2021Inventors: Melissa G.T. Christie, Ronald A. Drake, Vladimir P. Nikolski, Bushan K. Purushothaman, Xusheng Zhang
-
Patent number: 10898720Abstract: In some examples, a medical device system includes an electrode. The medical device system may include impedance measurement circuitry coupled to the electrode, the impedance measurement circuitry may be configured to generate an impedance signal indicating impedance proximate to the electrode. The medical device system may include processing circuitry that may be configured to identify a first component of the impedance signal. The first component of the impedance signal may be correlated to a cardiac event. The processing circuitry may be configured to determine that the cardiac event occurred based on the identification of the first component of the impedance signal.Type: GrantFiled: October 16, 2018Date of Patent: January 26, 2021Assignee: Medtronic, Inc.Inventors: Melissa G. T. Christie, Ronald A. Drake, Vladimir P. Nikolski, Bushan K. Purushothaman, Xusheng Zhang
-
Publication number: 20200398067Abstract: A medical device is configured to deliver anti-tachycardia pacing (ATP) in the presence of T-wave alternans. The device is configured to detect a ventricular tachyarrhythmia from a cardiac electrical signal received by the medical device. In response to the detected ventricular tachyarrhythmia, the device delivers a plurality of ATP pulses at alternating time intervals. The alternating time intervals comprise at least a first ATP time interval separating a first pair of the ATP pulses and a second ATP time interval different than the first ATP time interval. The second ATP time interval consecutively follows the first ATP time interval and separates a second pair of the ATP pulses.Type: ApplicationFiled: September 2, 2020Publication date: December 24, 2020Inventor: Vladimir P. Nikolski
-
Publication number: 20200298003Abstract: An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.Type: ApplicationFiled: June 8, 2020Publication date: September 24, 2020Inventors: Xusheng ZHANG, Yanina GRINBERG, Paul R. SOLHEIM, Troy E. JACKSON, Timothy A. EBELING, Vladimir P. NIKOLSKI
-
Publication number: 20200297993Abstract: This disclosure describes an implantable medical electrical lead and an ICD system utilizing the lead. The lead includes a lead body defining a proximal end and a distal portion, wherein at least a part of the distal portion of the lead body defines an undulating configuration. The lead includes a defibrillation electrode that includes a plurality of defibrillation electrode segments disposed along the undulating configuration spaced apart from one another by a distance. The lead also includes at least one electrode disposed between adjacent sections of the plurality of defibrillation sections. The at least one electrode is configured to deliver a pacing pulse to the heart and/or sense cardiac electrical activity of the heart.Type: ApplicationFiled: June 2, 2020Publication date: September 24, 2020Inventors: Mark T. Marshall, Gonzalo Martinez, Vladimir P. Nikolski, Nathan L. Olson, Kevin R. Seifert, Teresa A. Whitman
-
Publication number: 20200282203Abstract: Implantable medical electrical leads having electrodes arranged such that a defibrillation coil electrode and a pace/sense electrode(s) are concurrently positioned substantially over the ventricle when implanted as described. The leads include an elongated lead body having a distal portion and a proximal end, a connector at the proximal end of the lead body, a defibrillation electrode located along the distal portion of the lead body, wherein the defibrillation electrode includes a first electrode segment and a second electrode segment proximal to the first electrode segment by a distance. The leads may include at least one pace/sense electrode, which in some instances, is located between the first defibrillation electrode segment and the second defibrillation electrode segment.Type: ApplicationFiled: May 20, 2020Publication date: September 10, 2020Inventors: Mark T. Marshall, Jian Cao, Melissa G.T. Christie, Paul J. DeGroot, Vladimir P. Nikolski, Amy E. Thompson-Nauman
-
Patent number: 10765876Abstract: A medical device is configured to deliver anti-tachycardia pacing (ATP) in the presence of T-wave alternans. The device is configured to detect a ventricular tachyarrhythmia from a cardiac electrical signal received by the medical device. In response to the detected ventricular tachyarrhythmia, the device delivers a plurality of ATP pulses at alternating time intervals. The alternating time intervals comprise at least a first ATP time interval separating a first pair of the ATP pulses and a second ATP time interval different than the first ATP time interval. The second ATP time interval consecutively follows the first ATP time interval and separates a second pair of the ATP pulses.Type: GrantFiled: April 27, 2018Date of Patent: September 8, 2020Assignee: Medtronic, Inc.Inventor: Vladimir P. Nikolski
-
Patent number: 10675478Abstract: This disclosure describes an implantable medical electrical lead and an ICD system utilizing the lead. The lead includes a lead body defining a proximal end and a distal portion, wherein at least a part of the distal portion of the lead body defines an undulating configuration. The lead includes a defibrillation electrode that includes a plurality of defibrillation electrode segments disposed along the undulating configuration spaced apart from one another by a distance. The lead also includes at least one electrode disposed between adjacent sections of the plurality of defibrillation sections. The at least one electrode is configured to deliver a pacing pulse to the heart and/or sense cardiac electrical activity of the heart.Type: GrantFiled: December 9, 2015Date of Patent: June 9, 2020Assignee: Medtronic, Inc.Inventors: Mark T. Marshall, Gonzalo Martinez, Vladimir P. Nikolski, Nathan L. Olson, Kevin R. Seifert, Teresa A. Whitman
-
Patent number: 10675471Abstract: An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.Type: GrantFiled: August 15, 2017Date of Patent: June 9, 2020Assignee: Medtronic, Inc.Inventors: Xusheng Zhang, Yanina Grinberg, Paul R. Solheim, Troy E. Jackson, Timothy A. Ebeling, Vladimir P. Nikolski
-
Publication number: 20200171316Abstract: An extra-cardiovascular implantable cardioverter defibrillator (ICD) having a low voltage therapy module and a high voltage therapy module is configured to select, by a control module of the ICD, a pacing output configuration from at least a low-voltage pacing output configuration of the low voltage therapy module and a high-voltage pacing output configuration of the high voltage therapy module. The high voltage therapy module includes a high voltage capacitor having a first capacitance and the low voltage therapy module includes a plurality of low voltage capacitors each having up to a second capacitance that is less than the first capacitance. The ICD control module controls a respective one of the low voltage therapy module or the high voltage therapy module to deliver extra-cardiovascular pacing pulses in the selected pacing output configuration via extra-cardiovascular electrodes coupled to the ICD.Type: ApplicationFiled: February 10, 2020Publication date: June 4, 2020Inventors: David A. ANDERSON, Mark T. Marshall, Vladimir P. NIKOLSKI, Robert T. SAWCHUK, Amy E. THOMPSON-NAUMAN, John D. WAHLSTRAND, Gregory A. YOUNKER
-
Patent number: 10661073Abstract: Implantable medical electrical leads having electrodes arranged such that a defibrillation coil electrode and a pace/sense electrode(s) are concurrently positioned substantially over the ventricle when implanted as described. The leads include an elongated lead body having a distal portion and a proximal end, a connector at the proximal end of the lead body, a defibrillation electrode located along the distal portion of the lead body, wherein the defibrillation electrode includes a first electrode segment and a second electrode segment proximal to the first electrode segment by a distance. The leads may include at least one pace/sense electrode, which in some instances, is located between the first defibrillation electrode segment and the second defibrillation electrode segment.Type: GrantFiled: November 27, 2018Date of Patent: May 26, 2020Assignee: Medtronic, Inc.Inventors: Mark T. Marshall, Jian Cao, Melissa G. T. Christie, Paul J. Degroot, Vladimir P. Nikolski, Amy E. Thompson-Nauman
-
Publication number: 20200046975Abstract: An implantable medical device is configured to control a therapy module to couple a capacitor array comprising a plurality of capacitors to a plurality of extra-cardiovascular electrodes and control the therapy module to deliver a composite pacing pulse to a patient's heart via the plurality of extra-cardiovascular electrodes by sequentially discharging at least a portion of the plurality capacitors to produce a series of at least two individual pulses that define the composite pacing pulse.Type: ApplicationFiled: October 21, 2019Publication date: February 13, 2020Inventors: David A. ANDERSON, Mark T. MARSHALL, Vladimir P. NIKOLSKI, Robert T. SAWCHUK, Amy E. THOMPSON-NAUMAN, John D. WAHLSTRAND, Gregory A. YOUNKER